PTJ
TBIO

Paul Tudor Jones’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Paul Tudor Jones’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-232,549
Closed -$4.17M – 1634
2020
Q2 		$4.17M Buy
+232,549
New +$3.51M 0.21% 76

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Paul Tudor Jones's TBIO Position: Q3 2020 in Review

Paul Tudor Jones sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2020, closing a stake of 232,549 shares — an estimated $4.17M sold.

Paul Tudor Jones first reported a position in TBIO in Q2 2020 and held it in 1 quarter. The position peaked at $4.17M in Q2 2020. 132 funds tracked by Wall St. Rank hold TBIO as of Q3 2020.

  • Paul Tudor Jones reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Paul Tudor Jones sold 232,549 Translate Bio, Inc. Common Stock shares in Q3 2020, an estimated $4.17M.
  • Paul Tudor Jones first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Paul Tudor Jones's Translate Bio, Inc. Common Stock position peaked at $4.17M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2020.

Based on Tudor Investment Corp's 13F filing for Q3 2020, filed 16 Nov 2020.